This subject explores pathophysiological processes contributing to disease. This subject focuses on pathophysiological processes associated with musculoskeletal, cardiovascular and respiratory dysfunction. Relevant pharmacology is integrated throughout.
School of Biomedical Sciences
BMS192 or ( BMS130 and MCR101 )
BMS101, BMS102, BMS121, BMS122, BMS221, BMS222, BMS231, BMS232
PATHOPHYSIOOGICAL AND PHARMACOLOGICAL FOUNDATIONS
* Cell injury, adaptation and death
* Pharmacokinetics and pharmacodynamics
GENERAL PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Fluid, electrolyte and acid-base imbalances
* Pain and analgesic agents
* Inflammation and anti-inflammatory agents
* Infectious disease and antimicrobial agents
* Neoplastic disorders and antineoplastic agents
SYSTEMATIC PATHOPHYSIOLOGY AND ASSOCIATED PHARMACOLOGY
* Cardiovascular dysfunction (coagulopathy, hypertension, atherosclerosis, dysrhythmias, pump failure) and associated pharmacology
* Respiratory dysfunction (asthma, chronic airways limitation, hypoventilation, pulmonary hypertension) and associated pharmacology
* Musculoskeletal dysfunction (arthritis, osteoporosis, metabolic disorders, muscular dystrophy) and associated pharmacology
For any enquiries about subject selection or course structure please contact Student Central or firstname.lastname@example.org or phone on 1800 275 278.
For further information about Charles Sturt University, or this course offering, please contact info.csu on 1800 334 733 (free call within Australia) or enquire online.
The information contained in the 2019 CSU Handbook was accurate at the date of publication: September 2018. The University reserves the right to vary the information at any time without notice.